Exact Therapeutics AS
🇳🇴Norway
Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
Phase 2
Recruiting
- Conditions
- Locally Advanced Pancreatic Adenocarcinoma
- Interventions
- Combination Product: Acoustic Cluster TherapyDrug: Modified FOLFIRINOX
- First Posted Date
- 2025-02-27
- Last Posted Date
- 2025-10-14
- Lead Sponsor
- EXACT Therapeutics AS
- Target Recruit Count
- 25
- Registration Number
- NCT06850623
- Locations
- 🇺🇸
HonorHealth Research Institute, Scottsdale, Arizona, United States
🇺🇸Henry Ford Centre, Detroit, Michigan, United States
🇺🇸Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
PS101-mediated ACT With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin
Phase 1
Terminated
- Conditions
- Solid TumorColorectal Cancer
- Interventions
- Drug: 20 uL/kg PS101Drug: 40 uL/kg PS101Device: Ultrasound
- First Posted Date
- 2019-07-16
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- EXACT Therapeutics AS
- Target Recruit Count
- 11
- Registration Number
- NCT04021277
- Locations
- 🇳🇴
Oslo University Hospital HF, Oslo, Norway
🇬🇧Cambridge University Hospitals NHS Foundation Trust, Addenbrookes Hospital, Cambridge, United Kingdom
🇬🇧Freeman Hospital, Newcastle Upon Tyne, United Kingdom
News
No news found